{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T07:41:19Z","timestamp":1791877279004,"version":"4.3.4"},"reference-count":124,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2019,7,31]],"date-time":"2019-07-31T00:00:00Z","timestamp":1564531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Hypertension is considered a major public health issue due to its high prevalence and subsequent risk of cardiovascular and kidney diseases. Thus, the search for new antihypertensive compounds remains of great interest. Snake venoms provide an abundant source of lead molecules that affect the cardiovascular system, which makes them prominent from a pharmaceutical perspective. Such snake venom components include bradykinin potentiating peptides (proline-rich oligopeptides), natriuretic peptides, phospholipases A2, serine-proteases and vascular endothelial growth factors. Some heparin binding hypotensive factors, three-finger toxins and 5\u2032 nucleotidases can also exert blood pressure lowering activity. Great advances have been made during the last decade regarding the understanding of the mechanism of action of these hypotensive proteins. Bradykinin potentiating peptides exert their action primarily by inhibiting the angiotensin-converting enzyme and increasing the effect of endogenous bradykinin. Snake venom phospholipases A2 are capable of reducing blood pressure through the production of arachidonic acid, a precursor of cyclooxygenase metabolites (prostaglandins or prostacyclin). Other snake venom proteins mimic the effects of endogenous kallikrein, natriuretic peptides or vascular endothelial growth factors. The aim of this work was to review the current state of knowledge regarding snake venom components with potential antihypertensive activity and their mechanisms of action.<\/jats:p>","DOI":"10.3390\/molecules24152778","type":"journal-article","created":{"date-parts":[[2019,7,31]],"date-time":"2019-07-31T11:37:07Z","timestamp":1564573027000},"page":"2778","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":80,"title":["Hypotensive Snake Venom Components\u2014A Mini-Review"],"prefix":"10.3390","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1921-1452","authenticated-orcid":false,"given":"Orsolya","family":"P\u00e9terfi","sequence":"first","affiliation":[{"name":"Faculty of Pharmacy, University of Medicine, Pharmacy, Science and Technology of Targu Mures, Gheorghe Marinescu Street No. 38, 540139 Tirgu Mures, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3777-3712","authenticated-orcid":false,"given":"Francisc","family":"Boda","sequence":"additional","affiliation":[{"name":"Department of Fundamental Pharmaceutical Sciences, Faculty of Pharmacy, University of Medicine, Pharmacy, Science and Technology of Targu Mures, Gheorghe Marinescu Street No. 38, 540139 Tirgu Mures, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8740-0212","authenticated-orcid":false,"given":"Zolt\u00e1n","family":"Szab\u00f3","sequence":"additional","affiliation":[{"name":"Department of Specialty Pharmaceutical Sciences, Faculty of Pharmacy, University of Medicine, Pharmacy, Science and Technology of Targu Mures, Gheorghe Marinescu Street No. 38, 540139 Tirgu Mures, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8916-1780","authenticated-orcid":false,"given":"Elek","family":"Ferencz","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, University of Medicine, Pharmacy, Science and Technology of Targu Mures, Gheorghe Marinescu Street No. 38, 540139 Tirgu Mures, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e1szl\u00f3","family":"B\u00e1ba","sequence":"additional","affiliation":[{"name":"Department of Specialty Pharmaceutical Sciences, Faculty of Pharmacy, University of Medicine, Pharmacy, Science and Technology of Targu Mures, Gheorghe Marinescu Street No. 38, 540139 Tirgu Mures, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,7,31]]},"reference":[{"key":"ref_1","unstructured":"Wilkins, E., Wilson, L., Wickramasinghe, K., Bhatnagar, P., Leal, J., Luengo-Fernandez, R., Burns, R., Rayner, M., and Townsend, N. (2017). European Cardiovascular Disease Statistics 2017, European Heart Network."},{"key":"ref_2","unstructured":"World Health Organization (2019, April 11). Cardiovascular diseases (CVDs). Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/cardiovascular-diseases-(cvds)."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.jash.2016.08.006","article-title":"Worldwide prevalence of hypertension exceeds 1.3 billion","volume":"10","author":"Bloch","year":"2016","journal-title":"J. Am. Soc. Hypertens."},{"key":"ref_4","first-page":"3021","article-title":"2018 ESC\/ESH Guidelines for the management of arterial hypertension","volume":"39","author":"Williams","year":"2018","journal-title":"J. Hypertens."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"228","DOI":"10.11622\/smedj.2016087","article-title":"Secondary hypertension in adults","volume":"57","author":"Puar","year":"2016","journal-title":"Singap. Med. J."},{"key":"ref_6","unstructured":"Skorecki, K., Chertow, G.M., Marsden, P.A., Taal, M.W., and Yu, A.S.L. (2016). Primary and Secondary Hypertension. Brenner and Rector\u2019s The Kidney, Elsevier."},{"key":"ref_7","unstructured":"World Health Organization (2019, April 11). A Global Brief on Hypertension. Available online: https:\/\/www.who.int\/cardiovascular_diseases\/publications\/global_brief_hypertension\/en\/."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0140-6736(15)01225-8","article-title":"Blood pressure lowering for prevention of cardiovascular disease and death: A systematic review and meta-analysis","volume":"387","author":"Ettehad","year":"2016","journal-title":"Lancet"},{"key":"ref_9","first-page":"28","article-title":"Association of Blood Pressure Lowering with Mortality and Cardiovascular Disease Across Blood Pressure Levels","volume":"178","author":"Carlberg","year":"2017","journal-title":"JAMA Intern. Med."},{"key":"ref_10","first-page":"455","article-title":"From snake venom to ACE inhibitor\u2014The discovery and rise of captopril","volume":"282","author":"Bryan","year":"2009","journal-title":"Pharm. J."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.bbagen.2016.12.022","article-title":"Minor snake venom proteins: Structure, function and potential applications","volume":"1861","author":"Cologna","year":"2017","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"437","DOI":"10.2174\/1568006043335808","article-title":"Hypotensive Agents from Snake Venoms","volume":"4","author":"Joseph","year":"2004","journal-title":"Curr. Drug Target Cardiovasc. Hematol. Disord."},{"key":"ref_13","unstructured":"Mackessy, S.P. (2009). Handbook of Venoms and Toxins of Reptiles, CRC Press. [1st ed.]."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1177\/0310057X9802600510","article-title":"The cardiovascular, coagulation and haematological effects of Tiger Snake (Notechis scutatus) venom","volume":"26","author":"Tibballs","year":"1998","journal-title":"Anaesth. Intensive Care"},{"key":"ref_15","first-page":"10","article-title":"The relaxant effect of the Montivipera bornmuelleri snake venom on vascular contractility","volume":"7","author":"Accary","year":"2016","journal-title":"J. Venom Res."},{"key":"ref_16","unstructured":"Wexler, P. (2014). Animal Venoms in Medicine. Encyclopedia of Toxicology, Academic Press."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.2174\/0929867324666170605091546","article-title":"Snake Venom: From Deadly Toxins to Life-saving Therapeutics","volume":"24","author":"Waheed","year":"2017","journal-title":"Curr. Med. Chem."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"81","DOI":"10.12816\/0034637","article-title":"Intersexual Variation in Tail Length, Venom Composition Toxicity, and Anticancer Activity of Cerastes Cerastes (Viperidae)","volume":"66","author":"Sarhan","year":"2017","journal-title":"Egypt. J. Hosp. Med."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Amorim, F.G., Costa, T.R., Baiwir, D., De Pauw, E., Quinton, L., and Sampaio, S.V. (2018). Proteopeptidomic, functional and immunoreactivity characterization of Bothrops moojeni snake venom: Influence of snake gender on venom composition. Toxins, 10.","DOI":"10.3390\/toxins10050177"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"9205","DOI":"10.1073\/pnas.1405484111","article-title":"Medically important differences in snake venom composition are dictated by distinct postgenomic mechanisms","volume":"111","author":"Casewell","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1111\/bjh.14591","article-title":"Haemotoxic snake venoms: their functional activity, impact on snakebite victims and pharmaceutical promise","volume":"177","author":"Slagboom","year":"2017","journal-title":"Br. J. Haematol."},{"key":"ref_22","first-page":"1","article-title":"From Toxins to Drugs: Chemistry and Pharmacology of Animal Venom and other Secretions","volume":"1","author":"Mtewa","year":"2019","journal-title":"Online J. Compliment. Altern. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1002\/cphy.c130040","article-title":"Classical Renin-Angiotensin system in kidney physiology","volume":"4","author":"Sparks","year":"2014","journal-title":"Compr. Physiol."},{"key":"ref_24","unstructured":"Fountain, J.H., and Lappin, S.L. (2019, June 09). Physiology, Renin Angiotensin System, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK470410\/."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Radis-Baptista, G. (2013). Venom Bradykinin-Related Peptides (BRPs) and Its Multiple Biological Roles. An Integrated View of the Molecular Recognition and Toxinology\u2014From Analytical Procedures to Biomedical Applications, IntechOpen.","DOI":"10.5772\/3429"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s40256-016-0173-4","article-title":"Unraveling the Pivotal Role of Bradykinin in ACE Inhibitor Activity","volume":"16","author":"Taddei","year":"2016","journal-title":"Am. J. Cardiovasc. Drugs"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.advenzreg.2011.09.005","article-title":"Phospholipase C signaling and calcium influx","volume":"52","author":"Putney","year":"2012","journal-title":"Adv. Biol. Regul."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/HYPERTENSIONAHA.117.10271","article-title":"Mechanisms of VEGF (Vascular Endothelial Growth Factor) Inhibitor\u2013Associated Hypertension and Vascular Disease","volume":"71","author":"Pandey","year":"2018","journal-title":"Hypertension"},{"key":"ref_29","first-page":"8","article-title":"Argininosuccinate synthase: At the center of arginine metabolism","volume":"2","author":"Haines","year":"2011","journal-title":"Int. J. Biochem. Mol. Biol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1152\/ajpheart.00216.2004","article-title":"Mathematical modeling of the nitric oxide\/cGMP pathway in the vascular smooth muscle cell","volume":"289","author":"Yang","year":"2005","journal-title":"AJP Heart Circ. Physiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"E18","DOI":"10.1093\/eurheartj\/sul026","article-title":"Clinical application of the natriuretic peptides in heart failure","volume":"8","author":"Chen","year":"2006","journal-title":"Eur. Heart J. Suppl."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.tips.2017.03.003","article-title":"Targeting the Prostacyclin Pathway: Beyond Pulmonary Arterial Hypertension","volume":"38","author":"Pluchart","year":"2017","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"24145","DOI":"10.1074\/jbc.M802278200","article-title":"Phosphorylation of the cAMP-dependent protein kinase (PKA) regulatory subunit modulates PKA-AKAP interaction, substrate phosphorylation, and calcium signaling in cardiac cells","volume":"283","author":"Manni","year":"2008","journal-title":"J. Biol. Chem."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s10989-017-9575-7","article-title":"Bj-PRO-5a and Bj-PRO 10c Found at C-Type Natriuretic Peptide Precursor of Bothrops jararaca Change Renal Function of Hypertensive Rats","volume":"23","author":"Xavier","year":"2017","journal-title":"Int. J. Pept. Res. Ther."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.bcp.2010.12.016","article-title":"Bj-PRO-5a, a natural angiotensin-converting enzyme inhibitor, promotes vasodilatation mediated by both bradykinin B2 and M1 muscarinic acetylcholine receptors","volume":"81","author":"Morais","year":"2011","journal-title":"Biochem. Pharmacol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/cyto.a.20963","article-title":"The snake venom peptide Bj-PRO-7a is a M1 muscarinic acetylcholine receptor agonist","volume":"79","author":"Negraes","year":"2011","journal-title":"Cytom. Part A"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.peptides.2013.07.016","article-title":"Proline rich-oligopeptides: Diverse mechanisms for antihypertensive action","volume":"48","author":"Morais","year":"2013","journal-title":"Peptides"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"20022","DOI":"10.1074\/jbc.M109.021089","article-title":"Argininosuccinate synthetase is a functional target for a snake venom anti-hypertensive peptide. Role in arginine and nitrix oxide production","volume":"284","author":"Guerreiro","year":"2009","journal-title":"J. Biol. Chem."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1038\/hr.2010.208","article-title":"Brain nitric oxide production by a proline-rich decapeptide from Bothrops jararaca venom improves baroreflex sensitivity of spontaneously hypertensive rats","volume":"33","author":"Lameu","year":"2010","journal-title":"Hypertens. Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s00726-013-1630-x","article-title":"Insights into cardiovascular effects of proline-rich oligopeptide (Bj-PRO-10c) revealed by structure-activity analyses: Dissociation of antihypertensive and bradycardic effects","volume":"2014","author":"Paschoal","year":"2014","journal-title":"Amino Acids"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/j.bbagen.2015.02.005","article-title":"New proline-rich oligopeptides from the venom of African adders: Insights into the hypotensive effect of the venoms","volume":"1850","author":"Kodama","year":"2015","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.toxicon.2014.07.011","article-title":"A new structurally atypical bradykinin-potentiating peptide isolated from Crotalus durissus cascavella venom (South American rattlesnake)","volume":"90","author":"Lopes","year":"2014","journal-title":"Toxicon"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.peptides.2018.01.015","article-title":"LmrBPP9: A synthetic bradykinin-potentiating peptide from Lachesis muta rhombeata venom that inhibits the angiotensin-converting enzyme activity in vitro and reduces the blood pressure of hypertensive rats","volume":"102","author":"Bendhack","year":"2018","journal-title":"Peptides"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12953-016-0090-0","article-title":"Isolation and characterization of Bradykinin potentiating peptides from Agkistrodon bilineatus venom","volume":"14","author":"Munawar","year":"2016","journal-title":"Proteome Sci."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s10989-011-9254-z","article-title":"Isolation and Characterization of a Natriuretic Peptide from Crotalus oreganus abyssus (Grand Canyon Rattlesnake) and its Effects on Systemic Blood Pressure and Nitrite Levels","volume":"17","author":"Almeida","year":"2011","journal-title":"Int. J. Pept. Res. Ther."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.peptides.2012.05.005","article-title":"Vascular effects and electrolyte homeostasis of the natriuretic peptide isolated from Crotalus oreganus abyssus (North American Grand Canyon rattlesnake) venom","volume":"36","author":"Baldasso","year":"2012","journal-title":"Peptides"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3858\/emm.2012.44.6.041","article-title":"Dendroaspis natriuretic peptide regulates the cardiac l-type ca2+ channel activity by the phosphorylation of \u03b11c proteins","volume":"44","author":"Park","year":"2012","journal-title":"Exp. Mol. Med."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.toxicon.2008.08.014","article-title":"Renal and vascular effects of the natriuretic peptide isolated from Crotalus durissus cascavella venom","volume":"52","author":"Evangelista","year":"2008","journal-title":"Toxicon"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S0014-5793(03)01455-8","article-title":"Functional and structural characterization of a novel member of the natriuretic family of peptides from the venom of Pseudocerastes persicus","volume":"557","author":"Amininasab","year":"2004","journal-title":"FEBS Lett."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1016\/j.biochi.2006.06.014","article-title":"Cloning and characterisation of natriuretic peptides from the venom glands of Australian elapids","volume":"88","author":"Flight","year":"2006","journal-title":"Biochimie"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jpba.2012.04.008","article-title":"Isolation and expression of a hypotensive and anti-platelet acidic phospholipase A2 from Bothrops moojeni snake venom","volume":"73","author":"Silveira","year":"2013","journal-title":"J. Pharm. Biomed. Anal."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0006-2952(02)01210-8","article-title":"Structural and functional characterization of an acidic platelet aggregation inhibitor and hypotensive phospholipase A2 from Bothrops jararacussu snake venom","volume":"64","author":"Soares","year":"2002","journal-title":"Biochem. Pharmacol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ejphar.2013.11.028","article-title":"Hypotensive and vascular relaxant effects of phospholipase A2 toxins from Papuan taipan (Oxyuranus scutellatus) venom","volume":"723","author":"Chaisakul","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1002\/jsfa.4733","article-title":"Isolation and characterisation of a kallikrein-like enzyme from Agkistrodon halys pallas snake venom","volume":"92","author":"Zhang","year":"2012","journal-title":"J. Sci. Food Agric."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1016\/j.febslet.2007.05.047","article-title":"Identification and characterization of Harobin, a novel fibrino(geno)lytic serine protease from a sea snake (Lapemis hardwickii)","volume":"581","author":"He","year":"2007","journal-title":"FEBS Lett."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s40409-018-0176-5","article-title":"Kn-Ba: A novel serine protease isolated from Bitis arietans snake venom with fibrinogenolytic and kinin-releasing activities","volume":"24","author":"Megale","year":"2018","journal-title":"J. Venom. Anim. Toxins Incl. Trop. Dis."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S1046-5928(03)00053-6","article-title":"Kallikrein-like proteinase from bushmaster snake venom","volume":"30","author":"Felicori","year":"2003","journal-title":"Protein Expr. Purif."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Vaiyapuri, S., Harrison, R.A., Bicknell, A.B., Gibbins, J.M., and Hutchinson, G. (2010). Purification and functional characterisation of rhinocerase, a novel serine protease from the venom of Bitis gabonica rhinoceros. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0009687"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1006\/bbrc.2001.4452","article-title":"Fibrinogenolytic proteases isolated from the snake venom of Taiwan Habu: Serine proteases with kallikrein-like and angiotensin-degrading activities","volume":"281","author":"Hung","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"46304","DOI":"10.1074\/jbc.M403687200","article-title":"A novel snake venom vascular endothelial growth factor (VEGF) predominantly induces vascular permeability through preferential signaling via VEGF receptor-1","volume":"279","author":"Takahashi","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.abb.2005.05.020","article-title":"Specific distribution of VEGF-F in Viperinae snake venoms: Isolation and characterization of a VEGF-F from the venom of Daboia russelli siamensis","volume":"439","author":"Tokunaga","year":"2005","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_62","first-page":"287","article-title":"FS2, a mamba venom toxin, is a specific blocker of the L-type calcium channels","volume":"21","author":"Yasuda","year":"1994","journal-title":"Artery"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1254\/jjp.68.305","article-title":"Smooth Muscle Relaxing and Hypotensive Activities of Synthetic Calciseptine and the Homologous Snake Venom Peptide FS2","volume":"68","author":"Watanabe","year":"2008","journal-title":"Jpn. J. Pharmacol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"11796","DOI":"10.1021\/bi990562z","article-title":"Vascular endothelial growth factor VEGF-like heparin-binding protein from the venom of Vipera aspis aspis (Aspic viper)","volume":"38","author":"Komori","year":"1999","journal-title":"Biochemistry"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.bbrc.2012.11.129","article-title":"Why myotoxin-containing snake venoms possess powerful nucleotidases?","volume":"430","author":"Caccin","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1476-5381.1965.tb02091.x","article-title":"A Bradykinin Potentiating Factor (BPF) Present in the Venom of Bothrops Jararaca","volume":"24","author":"Ferreira","year":"1965","journal-title":"Br. J. Pharmacol. Chemother."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.toxicon.2011.07.013","article-title":"Bradykinin-potentiating peptides: Beyond captopril","volume":"59","author":"Camargo","year":"2012","journal-title":"Toxicon"},{"key":"ref_68","first-page":"124","article-title":"The kinin system-bradykinin: Biological effects and clinical implications. Multiple role of the kinin system-bradykinin","volume":"11","author":"Golias","year":"2007","journal-title":"Hippokratia"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/sj.bjp.0705669","article-title":"The role of bradykinin, AT 2 and angiotensin 1\u20137 receptors in the EDRF-dependent vasodilator effect of angiotensin II on the isolated mesenteric vascular bed of the rat","volume":"141","author":"Resende","year":"2004","journal-title":"Br. J. Pharmacol."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Munawar, A., Ali, S.A., Akrem, A., and Betzel, C. (2018). Snake venom peptides: Tools of biodiscovery. Toxins, 10.","DOI":"10.3390\/toxins10110474"},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"El-Shemy, H.A. (2013). Applications of Snake Venom Proline-Rich Oligopeptides (Bj-PROs) in Disease Conditions Resulting from Deficient Nitric Oxide Production. Drug Discovery, IntechOpen.","DOI":"10.5772\/3388"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0008-6363(01)00238-3","article-title":"The role of the natriuretic peptides in the cardiovascular system","volume":"51","author":"Suzuki","year":"2001","journal-title":"Cardiovasc. Res."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1152\/advan.00177.2016","article-title":"The renal and cardiovascular effects of natriuretic peptides","volume":"41","author":"Wong","year":"2017","journal-title":"Adv. Physiol. Educ."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.toxicon.2011.03.017","article-title":"From snake venom toxins to therapeutics\u2014Cardiovascular examples","volume":"59","author":"Koh","year":"2012","journal-title":"Toxicon"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"F473","DOI":"10.1152\/ajprenal.1990.258.3.F473","article-title":"Atrial natriuretic peptide differentially modulates T- and L-type calcium channels","volume":"258","author":"McCarthy","year":"2017","journal-title":"Am. J. Physiol. Physiol."},{"key":"ref_76","first-page":"365","article-title":"Inhibitory effect of C-type natriuretic peptide on L-type calcium channel currents in gastric antral myocytes of guinea pigs","volume":"25","author":"Sun","year":"2006","journal-title":"Gen. Physiol. Biophys."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.regpep.2008.06.006","article-title":"B-type natriuretic peptide (BNP) attenuates the L-type calcium current and regulates ventricular myocyte function","volume":"151","author":"Sodi","year":"2008","journal-title":"Regul. Pept."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.cardiores.2005.10.001","article-title":"The role of natriuretic peptides in cardioprotection","volume":"69","author":"Nishikimi","year":"2006","journal-title":"Cardiovasc. Res."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"4080","DOI":"10.2174\/138161210794519237","article-title":"C-type Natriuretic Peptide (CNP): Cardiovascular Roles and Potential as a Therapeutic Target","volume":"16","author":"Lumsden","year":"2011","journal-title":"Curr. Pharm. Des."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"S345","DOI":"10.4103\/2230-8210.86978","article-title":"Natriuretic peptides: Diagnostic and therapeutic use","volume":"15","author":"Pandit","year":"2011","journal-title":"Indian J. Endocrinol. Metab."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"13928","DOI":"10.1016\/S0021-9258(19)49658-0","article-title":"A new member of the natriuretic peptide family is present in the venom of the green mamba (Dendroaspis angusticeps)","volume":"267","author":"Schweitz","year":"1992","journal-title":"J. Biol. Chem."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1046\/j.1523-1755.1999.00573.x","article-title":"Renal actions of synthetic Dendroaspis natriuretic peptide","volume":"56","author":"Lisy","year":"1999","journal-title":"Kidney Int."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jacc.2008.02.077","article-title":"Design, Synthesis, and Actions of a Novel Chimeric Natriuretic Peptide: CD-NP","volume":"52","author":"Lisy","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.toxicon.2010.12.001","article-title":"Natriuretic peptide drug leads from snake venom","volume":"59","author":"Vink","year":"2012","journal-title":"Toxicon"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.jacbts.2016.10.001","article-title":"Innovative Therapeutics: Designer Natriuretic Peptides","volume":"1","author":"Meems","year":"2016","journal-title":"JACC Basic Transl. Sci."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/cpt.974","article-title":"A Human Study to Evaluate Safety, Tolerability, and Cyclic GMP Activating Properties of Cenderitide in Subjects with Stable Chronic Heart Failure","volume":"104","author":"Kawakami","year":"2018","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ijcard.2018.06.002","article-title":"Natriuretic peptide based therapeutics for heart failure: Cenderitide: A novel first-in-class designer natriuretic peptide","volume":"281","author":"Ichiki","year":"2019","journal-title":"Int. J. Cardiol."},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Siang, A.S., Doley, R., Vonk, F.J., and Kini, R.M. (2010). Transcriptomic analysis of the venom gland of the red-headed krait (Bungarus flaviceps) using expressed sequence tags. BMC Mol. Biol., 11.","DOI":"10.1186\/1471-2199-11-24"},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Sridharan, S., and Kini, R.M. (2015). Snake venom natriuretic peptides: Potential molecular probes. BMC Pharmacol. Toxicol., 16.","DOI":"10.1186\/2050-6511-16-S1-A87"},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Jiang, Y., Li, Y., Lee, W., Xu, X., Zhang, Y., Zhao, R., Zhang, Y., and Wang, W. (2011). Venom gland transcriptomes of two elapid snakes (Bungarus multicinctus and Naja atra) and evolution of toxin genes. BMC Genom., 12.","DOI":"10.1186\/1471-2164-12-1"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.toxicon.2005.03.006","article-title":"Identification of novel bradykinin-potentiating peptides and C-type natriuretic peptide from Lachesis muta venom","volume":"46","author":"Soares","year":"2005","journal-title":"Toxicon"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.bbrc.2004.11.171","article-title":"Novel natriuretic peptides from the venom of the inland taipan (Oxyuranus microlepidotus): Isolation, chemical and biological characterisation","volume":"327","author":"Fry","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"S237","DOI":"10.1194\/jlr.R800033-JLR200","article-title":"Phospholipase A 2 structure\/function, mechanism, and signaling","volume":"50","author":"Burke","year":"2009","journal-title":"J. Lipid Res."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"6592820","DOI":"10.1155\/2017\/6592820","article-title":"Snake Venom PLA 2, a Promising Target for Broad-Spectrum Antivenom Drug Development","volume":"2017","author":"Xiao","year":"2017","journal-title":"BioMed Res. Int."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.toxicon.2005.02.020","article-title":"Snake venom serine proteinases: Sequence homology vs. substrate specificity, a paradox to be solved","volume":"45","author":"Serrano","year":"2005","journal-title":"Toxicon"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.toxicon.2012.09.003","article-title":"The long road of research on snake venom serine proteinases","volume":"62","author":"Serrano","year":"2013","journal-title":"Toxicon"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.toxlet.2018.02.004","article-title":"Synergistic strategies of predominant toxins in snake venoms","volume":"287","author":"Xiong","year":"2018","journal-title":"Toxicol. Lett."},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Gopalakrishnakone, P., and Calvete, J. (2016). Snake Venom Phospholipase A2: Evolution and Diversity. Venom Genomics and Proteomics, Springer.","DOI":"10.1007\/978-94-007-6416-3"},{"key":"ref_99","first-page":"169","article-title":"Signal transduction by vascular endothelial growth factor receptors","volume":"437","author":"Koch","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/nrm.2016.87","article-title":"Mechanisms and regulation of endothelial VEGF receptor signalling","volume":"17","author":"Simons","year":"2016","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1161\/hy0302.105398","article-title":"Exaggerated hypotensive effect of vascular endothelial growth factor in spontaneously hypertensive rats","volume":"39","author":"Yang","year":"2002","journal-title":"Hypertension"},{"key":"ref_102","first-page":"473","article-title":"Vascular endothelial growth factor-mediated endothelium-dependent relaxation is blunted in spontaneously hypertensive rats","volume":"296","author":"Liu","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1111\/jcmm.13089","article-title":"VEGF165 induces differentiation of hair follicle stem cells into endothelial cells and plays a role in in vivo angiogenesis","volume":"21","author":"Quan","year":"2017","journal-title":"J. Cell. Mol. Med."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/j.bbagen.2006.06.010","article-title":"The vascular endothelial growth factor VEGF165 induces perlecan synthesis via VEGF receptor-2 in cultured human brain microvascular endothelial cells","volume":"1760","author":"Kaji","year":"2006","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1161\/hq0701.093686","article-title":"Mechanism of action and pharmacology of unfractionated heparin","volume":"21","author":"Hirsh","year":"2001","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1161\/HYPERTENSIONAHA.110.156877","article-title":"Heparin induces rat aorta relaxation via integrin-dependent activation of muscarinic M3 receptors","volume":"56","author":"Medeiros","year":"2010","journal-title":"Hypertension"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"17","DOI":"10.4331\/wjbc.v10.i1.17","article-title":"Last decade update for three-finger toxins: Newly emerging structures and biological activities","volume":"10","author":"Utkin","year":"2018","journal-title":"World J. Biol. Chem."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.toxicon.2010.07.010","article-title":"Structure, function and evolution of three-finger toxins: Mini proteins with multiple targets","volume":"56","author":"Kini","year":"2010","journal-title":"Toxicon"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"110","DOI":"10.2174\/1874467208666150507105845","article-title":"Pharmacology of L-type Calcium Channels: Novel Drugs for Old Targets?","volume":"8","author":"Striessnig","year":"2015","journal-title":"Curr. Mol. Pharmacol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1124\/pr.114.009654","article-title":"The Physiology, Pathology, and Pharmacology of Voltage-Gated Calcium Channels and Their Future Therapeutic Potential","volume":"67","author":"Zamponi","year":"2015","journal-title":"Pharmacol. Rev."},{"key":"ref_111","unstructured":"Kaneez, F.S. (2018). L-Type Calcium Channels: Structure and Functions. Ion Channels in Health and Sickness, IntechOpen."},{"key":"ref_112","first-page":"33","article-title":"Increased response to high KCl-induced elevation in the intracellular-Ca2+ concentration in differentiated NG108-15 cell and the inhibitory effect of the L-Type Ca2+ channel blocker, calciseptine","volume":"31","author":"Imanishi","year":"2006","journal-title":"Neurochem. Res."},{"key":"ref_113","first-page":"1315","article-title":"Vanillic acid as a novel specific inhibitor of snake venom 5\u2032-nucleotidase: A pharmacological tool in evaluating the role of the enzyme in snake envenomation","volume":"74","author":"Dhananjaya","year":"2009","journal-title":"Biochemistry"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0041-0101(01)00232-X","article-title":"Ophidian envenomation strategies and the role of purines","volume":"40","author":"Aird","year":"2002","journal-title":"Toxicon"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1080\/14789450.2017.1377613","article-title":"Venom peptides as therapeutics: Advances, challenges and the future of venom-peptide discovery","volume":"14","author":"Robinson","year":"2017","journal-title":"Expert Rev. Proteom."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jprot.2014.10.002","article-title":"Snake venom serine proteinases specificity mapping by proteomic identification of cleavage sites","volume":"113","author":"Zelanis","year":"2015","journal-title":"J. Proteom."},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"Sanhajariya, S., Duffull, S.B., and Isbister, G.K. (2018). Pharmacokinetics of snake venom. Toxins, 10.","DOI":"10.3390\/toxins10020073"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.toxicon.2005.02.017","article-title":"The Bradykinin-potentiating peptides from venom gland and brain of Bothrops jararaca contain highly site specific inhibitors of the somatic angiotensin-converting enzyme","volume":"45","author":"Hayashi","year":"2005","journal-title":"Toxicon"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1038\/13423","article-title":"Design of angiotensin converting enzyme inhibitors","volume":"5","author":"Cushman","year":"1999","journal-title":"Nat. Med."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1161\/01.HYP.17.4.589","article-title":"History of the design of captopril and related inhibitors of angiotensin converting enzyme","volume":"17","author":"Cushman","year":"1991","journal-title":"Hypertension"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1177\/0091270009336233","article-title":"Pharmacodynamics of a novel designer natriuretic peptide, CD-NP, in a first-in-human clinical trial in healthy subjects","volume":"49","author":"Lee","year":"2009","journal-title":"J. Clin. Pharmacol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"E1037","DOI":"10.1016\/S0735-1097(12)61038-9","article-title":"Initial Experience With Subcutaneous Infusion of Cenderitide in Patients with Chronic Heart Failure","volume":"59","author":"Neutel","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.celrep.2013.07.016","article-title":"Glycine receptor \u03b12 subunit activation promotes cortical interneuron migration","volume":"4","author":"Avila","year":"2013","journal-title":"Cell Rep."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1574-695X.2008.00529.x","article-title":"Cellular response induced by a galactose-specific adhesin of enteroaggregative Escherichia coli in INT-407 cells","volume":"55","author":"Goyal","year":"2009","journal-title":"FEMS Immunol. Med. Microbiol."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/24\/15\/2778\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:11:27Z","timestamp":1760188287000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/24\/15\/2778"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,31]]},"references-count":124,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2019,8]]}},"alternative-id":["molecules24152778"],"URL":"https:\/\/doi.org\/10.3390\/molecules24152778","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,31]]}}}